Utility of serum ketone levels for assessment of myocardial glucose suppression for ^18F-fluorodeoxyglucose PET in patients referred for evaluation of endocarditis

[1]  Svati H Shah,et al.  Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical Trial , 2021, The Journal of Nuclear Medicine.

[2]  D. Berman,et al.  Appropriate Use Criteria for PET Myocardial Perfusion Imaging , 2020, The Journal of Nuclear Medicine.

[3]  A. Paterson,et al.  Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization , 2020, Journal of the American Heart Association.

[4]  E. Miller,et al.  Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis. , 2019, JACC. Cardiovascular imaging.

[5]  V. Murthy,et al.  Characterization of a highly effective preparation for suppression of myocardial glucose utilization , 2019, Journal of Nuclear Cardiology.

[6]  M. Rodriguez-Porcel,et al.  Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol , 2019, Journal of Nuclear Cardiology.

[7]  H. Bøtker,et al.  Ketone Body Infusion With 3‐Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study , 2017, Journal of the American Heart Association.

[8]  H. Verberne,et al.  Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in 18F-FDG PET Imaging , 2016, The Journal of Nuclear Medicine.

[9]  J. Zamorano,et al.  [2015 ESC Guidelines for the management of infective endocarditis]. , 2015, Kardiologia polska.

[10]  R. Blankstein,et al.  Evaluation of Known or Suspected Cardiac Sarcoidosis , 2016, Circulation. Cardiovascular imaging.

[11]  Susanna Price,et al.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). , 2015, European heart journal.

[12]  D. Berman,et al.  Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[13]  G. Kolodny,et al.  Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. , 2008, AJR. American journal of roentgenology.

[14]  David E. James,et al.  Regulated transport of the glucose transporter GLUT4 , 2002, Nature Reviews Molecular Cell Biology.

[15]  M. Palacín,et al.  Insulin-induced Recruitment of Glucose Transporter 4 (GLUT4) and GLUT1 in Isolated Rat Cardiac Myocytes , 1997, The Journal of Biological Chemistry.